PCSK9 Inhibition After Heart Transplantation
Condition: Vasculopathy Interventions: Biological: alirocumab; Biological: placebo Sponsors: Stanford University; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials